Scalper1 News
Allergan (AGN) reportedly obtained new patents for its Restasis eye drops, sending shares up sharply for the second day in a row on the stock market today. Although the company itself made no announcement, word started to go around Thursday that three patent applications the company filed in August had been granted and will appear in the next Orange Book. This is significant because the earlier composition patent on the product is due to expire in Scalper1 News
Scalper1 News